Approval · Notice of Compliance 11609 · 2010
DEXILANT: Notice of Compliance 11609
Issued July 22, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11609
- Date
- July 22, 2010
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Proton pump inhibitor
Products in this notice
Medicinal ingredients
- DEXLANSOPRAZOLE 30 MG per CAP
- DEXLANSOPRAZOLE 60 MG per CAP